Patents by Inventor Dharmpal Dodd

Dharmpal Dodd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080045536
    Abstract: Compounds having the formula (I), and enantiomers, and diastereomers, pharmaceutically-acceptable salts, thereof, are useful as kinase modulators, including MK2 modulation, wherein one of E and F is a nitrogen atom and the other of E and F is a carbon atom, Z is N or CR3, and R1, R2, R3, X and Y are as defined herein.
    Type: Application
    Filed: March 21, 2007
    Publication date: February 21, 2008
    Inventors: Wayne Vaccaro, Zhong Chen, Dharmpal Dodd, Tram Huynh, James Lin, Chunjian Liu, Christopher Mussari, John Tokarski, David Tortolani, Stephen Wrobleski, Shuqun Lin
  • Publication number: 20070078136
    Abstract: Compounds having the formula (1), and enantiomers, and diastereomers, pharmaceutically-acceptable salts, thereof, are usefuil as kinase modulators, including MK2 modulation, wherein one of E and F is a nitrogen atom and the other of E and F is a carbon atom, Z is N or CR3, and R1, R2, R3, X and Y are as defined herein.
    Type: Application
    Filed: September 21, 2006
    Publication date: April 5, 2007
    Inventors: Wayne Vaccaro, Zhong Chen, Dharmpal Dodd, Tram Huynh, James Lin, Chunjian Liu, Christopher Mussari, John Tokarski, David Tortolani, Stephen Wrobleski
  • Publication number: 20060063790
    Abstract: The invention encompasses compounds of Formula I, which are blockers of KCNQ channels. Blockers of KCNQ channels are known to enchance cognition in laboratory animals. The invention includes, salts, solvates, compositions, and methods of use.
    Type: Application
    Filed: September 8, 2005
    Publication date: March 23, 2006
    Inventors: Kevin Gillman, Dharmpal Dodd, John Starrett, Danielle Bocchino
  • Publication number: 20060052434
    Abstract: Pyrrolizine compounds having the formula (I), or pharmaceutically-acceptable salts thereof, are effective in treating inflammatory or immune diseases, where A is a four- to seven-membered saturated ring, K is O or S, and R1, R2, R3 n, and M are defined in the specification.
    Type: Application
    Filed: August 18, 2005
    Publication date: March 9, 2006
    Inventors: T. G. Dhar, Dharmpal Dodd, Dominique Potin, Michele Launay
  • Publication number: 20050080087
    Abstract: The present application describes compounds according to Formula I, wherein A, B, E, R1, R2, R3, R4, Y and Z are described herein. Additionally, the present application describes pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents. Finally, the present application describes methods of treatment using the compounds according to Formula I both alone and in combination with one or more additional therapeutic agents.
    Type: Application
    Filed: October 6, 2004
    Publication date: April 14, 2005
    Inventors: Annapurna Pendri, Samuel Gerritz, Dharmpal Dodd, Chongqing Sun
  • Publication number: 20050004151
    Abstract: Trisubstituted heteroaromatic compounds having the structure are provided, wherein X is C or N; A and B are each independently CH or N, with the proviso that A and B cannot both be CH; R1 is Ar-L-; R2 is hydrogen or alkyl; or R1 and R2 can be joined together to form a 4- to 7-membered cycloheteroalkyl ring; R3 to R8, Ar and L are as defined herein. A method for using these compounds to treat diseases associated with abnormal bone or mineral homeostasis is also provided.
    Type: Application
    Filed: May 26, 2004
    Publication date: January 6, 2005
    Inventors: Wu Yang, John Dickson, Christopher Cooper, Dharmpal Dodd, Zheming Ruan, Dora Schnur